Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.26) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.52) per share from the same period last year. The company reported quarterly sales of $2.483 million which missed the analyst consensus estimate of $5.500 million by 54.85 percent. This is a 12.30 percent increase over sales of $2.211 million the same period last year.